Article
Daclatasvir/peginterferon lambda-1a/ribavirin in patients with chronic HCV infection and haemophilia who are treatment naïve or prior relapsers to peginterferon alfa-2a/ribavirin.
Haemophilia : the official journal of the World Federation of Hemophilia - 1 Sept 2016
Santagostino E, Pol S, Olveira A, Reesink H W, van Erpecum K, Bogomolov P, Xu D, Critelli L, Srinivasan S, Cooney E
Abstract excerpt
AIM: This study explores the potential role of a novel interferon-containing regimen for treatment of patients with chronic hepatitis C (CHC) and underlying haemophilia. METHODS: This trial (NCT01741545) was an open-label, non-randomized phase 3 study, which included adult haemophiliacs with hepatitis C virus (HCV). Patients with HCV genotypes (GT)-2 or -3 were treated with Lambda-IFN/ribavirin (RBV)/daclatasvir...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.